#United States #Birmingham #Market Trends #RxBenefits #Pharmacy Benefits

Employers Revolve in Pharmacy Benefits Advisors

The pharmacy benefits landscape is undergoing a significant transformation, with a recent report from RxBenefits, the nation’s sole pharmacy benefits optimizer, shedding light on the current trends influencing employer decisions. According to the report published on October 12, 2026, an astonishing three-quarters of employers have either switched pharmacy benefits advisors in the past year or are keen on doing so in the next 12 months. With rising operational costs and heightened scrutiny regarding advisor compensation, the stability that once characterized these relationships seems to be fading away.

Insights from the Report

The findings come from a comprehensive survey conducted by FTI Consulting, which gathered insights from 601 employers and 300 employee benefits consultants. One of the most striking revelations is that 87% of respondents expressed a likelihood of switching their pharmacy benefits manager (PBM) upon contract renewal. This trend demonstrates an unsettling market instability that has not been witnessed in recent years.

Several key factors are propelling these shifts:

• - Escalating Costs: The continuous rise in drug prices shows no signs of leveling off, compelling employers to reconsider their advisory partnerships.
• - Demand for Transparency: What used to be a competitive edge—transparency—has since become an expectation. Employers are no longer satisfied with mere claims of transparency; they are demanding concrete evidence regarding savings, rebate specifics, and clinical outcomes.
• - Rigorous Federal Regulations: New federal laws mandating the disclosure of advisor compensations have introduced unprecedented scrutiny in the market, pressuring relationships between employers and their advisors.

Given these challenges, employers are prioritizing clinical management as a crucial criterion for evaluating providers. As pharmaceutical expenditures exceed $600 billion, they want partners who can demonstrate a capability to control costs, not just monitor spending metrics.

Key Findings within the Reporting Trends

The report outlines several notable trends influencing these decisions:
1. Trust in Advisors Short-lived: While employers value the input of benefits advisors, the increasing scrutiny over compensation has diminished long-standing trust.
2. Blurring Lines in Provider Types: The distinctions between transparent and traditional PBMs are becoming hazy, as employers become more discerning about the economic fundamentals of their plans.
3. Evaluation through Clinical Management: With the escalating costs tied to pharmaceuticals, clinical management is becoming pivotal in determining the value that advisors can provide.
4. Critical Examination of GLP-1 Strategies: Employers are treating the management of GLP-1 prescriptions as a standalone metric to evaluate provider readiness, expecting clear and comprehensive coverage policies.
5. Optimization over Replacement: The report emphasizes that merely switching vendors does not address the root problem. What is necessary is an active management approach supported by measurable outcomes.

Kyra Hagan, senior vice president of marketing and communications at RxBenefits, underscores the challenges faced by employers, stating, “Employers are stuck in a churn trap, and another vendor swap won't break it. What ends the cycle is proof, not just promises.” Thus, for advisors and employers alike, presenting documented savings and performance guarantees can justify remaining with their current partners rather than seeking a new one.

Upcoming Webinar Discussion

These themes will be further explored in an upcoming webinar titled "The Loyalty Gap: What 601 Employers and 300 Advisors Told Us About Pharmacy Benefits in 2026," set to take place on October 13, 2026. This session aims to delve deeper into the insights raised in the report, providing valuable guidance for benefits advisors managing self-insured plans.

For additional details on the report and its comprehensive analysis of the pharmacy benefits market, visit RxBenefits. This in-depth research can serve as a crucial resource for organizations striving to navigate the complexities of pharmacy costs while maintaining high-quality care and support for their members.